1. Home
  2. GLRE vs NPCE Comparison

GLRE vs NPCE Comparison

Compare GLRE & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlight Capital Re Ltd.

GLRE

Greenlight Capital Re Ltd.

HOLD

Current Price

$16.73

Market Cap

533.0M

Sector

Finance

ML Signal

HOLD

Logo Neuropace Inc.

NPCE

Neuropace Inc.

HOLD

Current Price

$16.47

Market Cap

536.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLRE
NPCE
Founded
2004
1997
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.0M
536.6M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
GLRE
NPCE
Price
$16.73
$16.47
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$18.33
AVG Volume (30 Days)
139.7K
133.0K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
75.00
29.03
EPS
1.05
N/A
Revenue
$729,777,000.00
$99,986,000.00
Revenue This Year
N/A
$0.90
Revenue Next Year
N/A
$24.46
P/E Ratio
$15.31
N/A
Revenue Growth
4.85
25.13
52 Week Low
$11.57
$7.56
52 Week High
$19.39
$19.60

Technical Indicators

Market Signals
Indicator
GLRE
NPCE
Relative Strength Index (RSI) 52.99 53.76
Support Level $13.77 $15.25
Resistance Level $17.02 $16.96
Average True Range (ATR) 0.48 0.68
MACD 0.14 0.09
Stochastic Oscillator 87.18 60.34

Price Performance

Historical Comparison
GLRE
NPCE

About GLRE Greenlight Capital Re Ltd.

Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.

About NPCE Neuropace Inc.

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Share on Social Networks: